Paloma Partners Management CO Corcept Therapeutics Inc Transaction History

Paloma Partners Management CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$10.11 - $14.04 $131,975 - $183,278	-13,054 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$12.06 - $16.96 $135,626 - $190,732	-11,246 Reduced 46.28%	13,054 $158,000
Q3 2019 Nov 14, 2019	BUY	$10.41 - $14.66 $252,963 - $356,238	24,300 New	24,300 $343,000
Q1 2019 May 15, 2019	SELL	$10.03 - $15.71 $129,457 - $202,768	-12,907 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$11.29 - $17.19 $145,720 - $221,871	12,907 New	12,907 $173,000
Q2 2018 Aug 14, 2018	SELL	$15.3 - $19.69 $544,756 - $701,062	-35,605 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$14.59 - $25.5 $519,476 - $907,927	35,605 New	35,605 $586,000
Q4 2017 Feb 14, 2018	SELL	$15.77 - $20.72 $984,663 - $1.29 Million	-62,439 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$12.3 - $19.3 $767,999 - $1.21 Million	62,439	62,439 $1.21 Million

349

86.1M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.32B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.